Atlas Trials

Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

Clinical trial NCT00264602 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00264602
Sponsor
Dana-Farber Cancer Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Lung Cancer
Start date
2009-02-18
Primary completion
2017-09-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.